Evidence map›Paper›PMID 19722835›Full record

ReviewFuture microbiology2009

Many substrates and functions of type II secretion: lessons learned from Legionella pneumophila.

Nicholas P Cianciotto

Open access · greenAbstract readReview
In one paragraph

Review in Future microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 83 citations in OpenAlex.

  1. Molecular evolution and adaptations ofFrontiers in cellular and infection microbiology · 2026
    Review
  2. Review
  3. Role ofFrontiers in microbiology · 2023
    Review
  4. Article
  5. Mitigation of Expression of Virulence Genes inPathogens (Basel, Switzerland) · 2020
    Article
  6. The phospholipase A effector PlaA from Legionella pneumophila: expression, purification and crystallization.Acta crystallographica. Section F, Structural biology communications · 2020
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Nicholas P CianciottoDepartment of Microbiology & Immunology, Northwestern University Medical School, 320 East Superior St., Chicago, IL 60611, USA. n-cianciotto@northwestern.edu
Northwestern University · US

Funding

TYPE II SECRETION AND LEGIONELLA PNEUMOPHILA INFECTIONR01AI043987 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CIANCIOTTO, NICHOLAS P · 1999 to 2017
$4.8M
Bacterial chitinases as new virulence factorsR21AI076693 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CIANCIOTTO, NICHOLAS P · 2009 to 2010
$433k
NIAID NIH HHS AI043987NIAID NIH HHS AI076 693NIAID NIH HHS R01 AI043987NIAID NIH HHS R21 AI076693
6 · The paper itself

Abstract

Type II secretion is one of six systems that exist in Gram-negative bacteria for the purpose of secreting proteins into the extracellular milieu and/or into host cells. This article will review the various recent studies of Legionella pneumophila that have increased our appreciation of the numbers, types and novelties of proteins that can be secreted via the type II system, as well as the many ways in which type II secretion can promote bacterial physiology, growth, ecology, intracellular infection and virulence. In this context, type II secretion represents a potentially important target for industrial and biomedical applications.

Indexed as

Bacterial ProteinsHumansLegionella pneumophilaMembrane Transport ProteinsModels, BiologicalProtein TransportVirulence FactorsBacterial ProteinsMembrane Transport ProteinsVirulence Factors

Identifiers

PMID19722835
PMCPMC2754693
OpenAlexW2139735735

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.